From: Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on
EGD n = 184; age 60 ± 17 years; 72 females (39%); 59 out-patients (32%); 160 available rtPCR SARS-CoV-2 (87%) | ||
Indication | Outcome [normal; endoscopic therapy; changed management] | |
1)Emergency/essential | 50 (27%) | 12; 56; 74% |
2)Urgent | 51 (28%) | 26; 24; 44% |
3)Non-urgent symptomatic | 59 (32%) | 31; 0; 7% |
4)Non-urgent asymptomatic | 24 (13%) | 21; 8; 0% |
Colonoscopy n = 118; age 64 ± 17 years; 49 females (42%); 37 out-patients (31%); 106 available rtPCR SARS-CoV-2 (90%) | ||
Indication | Outcome [normal; endoscopic therapy; changed management] | |
1)Emergency/essential: | 28 (24%) | 11; 36; 75% |
2)Urgent: | 38 (32%) | 32; 21; 32% |
3)Non-urgent symptomatic: | 31 (26%) | 39; 32; 10% |
4)Non-urgent asymptomatic: | 21 (18%) | 57; 10; 10% |
ERCP n = 42; age 71 ± 15 years; 23 females (55%); 42 in-patients (100%); 38 available rtPCR SARS-CoV-2 (91%) | ||
Indication | Outcome [normal; endoscopic therapy] | |
1)Emergency/essential: | 29 (69%) | 210; 97% |
2)Non-urgent asymptomatic: | 13 (31%) | 18; 92% |